Clinical Trials Browser

Phase 1 × Leukemia, Myeloid, Acute × asparaginase erwinia chrysanthemi recombinant × Clear all

NCT02283190 2018-03-12

1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute